Navigation Links
Lyon hypothesis


The Lyon hypothesis states that in cells with multiple X chromosomes, all but one is inactivated during mammalian embryogenesis. X-inactivation leads to clumped chromatin termed Barr bodies, which are generally considered inert. This formation of Barr bodies is called Lyonization.

In humans the X chromosome that is inactivated is determined by chance. In marsupials, however, the paternal X chromosome is always inactivated. Inactivation is achieved by methylation of the X chromosome DNA, a common way in which the cell silences particular genes. Certain animals have their coloring patters dictated by this phenomenon. For example, female Calico cats have unique patterns of fur due to certain areas where different X chromosomes are inactived. The X chromosomes that are activated express different coloring genes and lead to their mosaic fur color.

However, there are now reports that women still express many genes from their inactive X chromosomes, and that different women express different genes from the inactive X. Research by Carrel and Willard (2005) indicates that 15% of the genes on the inactive X chromosome are actually active across all women, and a further 10% of genes were switched on in some women.

The hypothesis was first stated by Mary F. Lyon in 1961 while she was studying the genetic consequences of radiation exposure, and therefore bears her name.

See also

Reference

  • Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females.. Nature 2005;434:400-404. PMID 15772666.
  • Lyon MF. Gene action in the X chromosome of the mouse (Mus musculus L). Nature 1961;190:372-373. PMID 13764598.

'"/>


(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received ... innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned ... syringe. The company’s solutions are the first Wharton’s jelly allograft product to be recognized ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead upcoming ... term focus on Type 2 diabetes and associated comorbidities. , Justin brings over ... and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a ... to discover a COVID cure or vaccine, the global economic downturn will only increase ... is not going away and capturing full value from every product launch is critical. ...
Breaking Biology News(10 mins):
Other biology definition